Consuelo
Gajate Fraile
Researcher in the period 2014-2015
Publications (21) Consuelo Gajate Fraile publications
2021
-
Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents
European Journal of Medicinal Chemistry, Vol. 209
-
Neutrophils drive endoplasmic reticulum stress-mediated apoptosis in cancer cells through arginase-1 release
Scientific Reports, Vol. 11, Núm. 1
2020
2018
-
Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells
European Journal of Medicinal Chemistry, Vol. 158, pp. 167-183
2017
-
Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine
PLoS Neglected Tropical Diseases, Vol. 11, Núm. 8
2016
-
Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy
Pharmacology and Therapeutics, Vol. 165, pp. 114-131
-
The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death
Acta Tropica, Vol. 162, pp. 180-187
2015
-
Eficacia de alquil-fosfolípidos frente a Strongyloides venezuelensis
XIX Congreso de la Sociedad Española de Parasitología (SOCEPA)
-
Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine
Oncotarget, Vol. 6, Núm. 16, pp. 14596-14613
-
Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications
Journal of Leukocyte Biology, Vol. 98, Núm. 5, pp. 739-759
-
Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling
Apoptosis, Vol. 20, Núm. 5, pp. 584-606
-
Lipid rafts as major platforms for signaling regulation in cancer
Advances in Biological Regulation, Vol. 57, pp. 130-146
-
Triggers and signaling cross-talk controlling cell death commitment
Cell Cycle
2014
-
Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine
Anti-Cancer Agents in Medicinal Chemistry, Vol. 14, Núm. 4, pp. 509-527
2013
-
Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast
Journal of Biological Chemistry, Vol. 288, Núm. 12, pp. 8405-8418
2012
-
Apoptotic mechanisms are involved in the death of Strongyloides venezuelensis after triggering of nitric oxide
Parasite Immunology, Vol. 34, Núm. 12, pp. 570-580
2009
-
Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis
Journal of Pharmacology and Experimental Therapeutics, Vol. 329, Núm. 2, pp. 439-449
2008
-
Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo
Cancer Research, Vol. 68, Núm. 13, pp. 5216-5225
2005
-
Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety
Journal of Medicinal Chemistry, Vol. 48, Núm. 2, pp. 556-568
2004
-
Synthesis and Biological Evaluation of New Selective Cytotoxic Cyclolignans Derived from Podophyllotoxin
Journal of Medicinal Chemistry, Vol. 47, Núm. 5, pp. 1214-1222